Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
  1. Home
  2. Media Statements
  3. Bayer Statement on Johnson Cert Petition Filing Deadline

Bayer Statement on Johnson Cert Petition Filing Deadline

March 19, 2021 in Media Statements

March 19, 2021 – Bayer said today that, after careful and extensive consideration, it has decided not to file a petition for certiorari with the U.S. Supreme Court in the case of Dewayne Johnson v Monsanto, which will bring an end to this California state case.

“The decision is not based on the merits of this case but reflects strategic considerations that the Hardeman case, tried in federal court and currently pending in the United States Court of Appeals for the Ninth Circuit, will serve as a better case for review by the Supreme Court. Bayer has great sympathy for Mr. Johnson and all people battling cancer yet continues to believe the Johnson verdict is not supported by the evidence or the law.

“Several factors contribute to making the Johnson case a less desirable candidate for Supreme Court review, including that the underlying opinion was issued by an intermediate level state court and the portion dealing with the key issue of federal preemption is unpublished, and thus will have no bearing on any case besides Johnson.

“In contrast, the Hardeman case, regardless of its outcome in the U.S. Court of Appeals, is a better candidate for Supreme Court review because the intermediate federal court is expected to publish a decision addressing the most significant federal questions at issue in the Rounduplitigation, including preemption and the admissibility of expert evidence.”

March 19, 2021
JohnsonRoundup
SHARE
  • Email
  • Twitter
  • Facebook
  • Google +
  • Pinterest
  • Tumblr
  • Linkedin
  • Vkontakte
  • WhatsApp
Category
  • Filings and Rulings
  • Five-Point Plan
  • In The News
  • Media Statements
  • Resources
    • Documents
    • Infographics
  • Uncategorized
Tags
Ads alesi Benefits carson ferro five-point plan Hardeman Infographics JCCP Johnson MDL Ninth Circuit Pilliod Prop 65 Regulators Roundup Science Settlement Shelton St. Louis City Supreme Court of California

Five-Point Plan to address potential future Roundup™ claims

Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.

Read about the five-point plan here.

Copyright © 2021, All Rights Reserved
Imprint
Privacy Statement

This site was prepared by the Bayer Group for educational purposes only.
For more information on glyphosate herbicides, visit: https://www.bayer.com/en/glyphosate-roundup.aspx.

Copyright © 2019, All Rights Reserved
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
  • Resources
  • Media Center